AI Science Tracker

HiDDEN finds malignant-like cell signals in early multiple-myeloma precursor samples

Broad Institute of MIT and Harvard; collaborating institutions · 2 Nov 2024 · biology

Discovery

HiDDEN finds malignant-like cell signals in early multiple-myeloma precursor samples

HiDDEN refines sample-level case labels at single-cell resolution. In human bone-marrow single-cell RNA-seq data, its labels tracked manual neoplastic-cell annotations in mixed precursor samples and inferred malignant-like cells in three low-purity MGUS samples that the original manual analysis had labeled as containing only healthy cells. The inferred cells were enriched for previously described malignancy-associated gene signatures. In a separate mouse demyelination dataset, HiDDEN identified an early endothelial subpopulation with expression changes associated with angiogenesis, blood–brain-barrier breakdown and extracellular-matrix responses.

Technology: HiDDEN, a machine-learning framework for refining disease/condition labels at single-cell resolution

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: retrospective or benchmark
  • Tested: HiDDEN refines sample-level case labels at single-cell resolution.
  • Still unknown: The MGUS finding is a transcriptomic inference in previously collected samples, computationally supported by known gene signatures and sample-purity estimates; the paper does not report independent pathology confirmation, clinical follow-up, or validation as a diagnostic test. The endothelial subpopulation was found in a mouse lesion model; its association with blood–brain-barrier dysfunction does not establish causality.
  • AI role: The model inferred which individual cells in case samples were affected rather than assigning the sample-level case label to all cells. This enabled the paper’s reanalysis of human myeloma precursor single-cell data and mouse demyelination single-nucleus data, yielding the specified malignancy and endothelial-population findings.

Evidence sources: https://www.nature.com/articles/s41467-024-53666-8.pdf

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Citations: in the top 10% of works of the same type, year and subfield (OpenAlex work metrics, 24 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open in the full catalog for filters, charts and related discoveries.